Autonomix Medical, Inc. to Present at the Virtual Investor Event Titled “A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System”

As part of the event, Lori Bisson, Chief Executive Officer of Autonomix will discuss its innovative technologies in development to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated.

SHARE

Live moderated video webcast on Monday, December 11 at 2:00 PM ET


THE WOODLANDS, TX — December 6, 2023Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will present at the Virtual Investor: A Breakthrough Medical Device for the Diagnosis and Treatment of Diseases of the Nervous System event on Monday, December 11, 2023 at 2:00 PM ET.

As part of the event, Lori Bisson, Chief Executive Officer of Autonomix will discuss its innovative technologies in development to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has shown the ability in non-clinical settings to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. In addition to the moderated discussion, interested parties will have the opportunity to submit questions live during the event. The Company will answer as many questions as possible in the time allowed.

A live video webcast of the presentation will be available on the Events page of the Company’s website (autonomix.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.

About Autonomix Medical, Inc. 


Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has shown the ability in non-clinical settings to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.   

We are initially developing our technology for pancreatic cancer pain and pancreatitis pain, conditions that can cause debilitating pain and need an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum.

For more information, visit autonomix.com and connect with the Company on Twitter, LinkedIn and Facebook

Forward Looking Statements

Some of the statements in this release are “forward-looking statements,” which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the ability of Autonomix to successfully develop its technology platform on a timely basis. Such forward-looking statements can be identified by the use of words such as ‘’should,‘’ ‘’may,‘’ ‘’intends,‘’ ‘’anticipates,‘’ ‘’believes,‘’ ‘’estimates,‘’ ‘’projects,‘’ ‘’forecasts,‘’ ‘’expects,‘’ ‘’plans,‘’ and ‘’proposes.‘’

Although Autonomix Medical, Inc. (or Autonomix) believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in the offering statement filed with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained, and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.

Autonomix is conducting an offering of its common stock pursuant to Regulation A promulgated pursuant to the Securities Act of 1933, as amended. The offering will be made only by means of an offering circular. An offering statement on Form 1-A relating to these securities has been filed with the U.S. Securities and Exchange Commission and has become qualified. The securities offered by Autonomix are highly speculative. Investing in shares of Autonomix involves significant risks. The investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. No public market currently exists for the securities, and if a public market develops following the offering, it may not continue.

Autonomix intends to list its securities on a national exchange and doing so entails significant ongoing corporate obligations including but not limited to disclosure, filing and notification requirements, as well compliance with applicable continued quantitative and qualitative listing standards. For additional information on Autonomix, the offering and any other related topics, please review the registration statement that can be found at the following location EDGAR Entity Landing Page (sec.gov). Additional information concerning Risk Factors related to the offering, including those related to the business, government regulations, intellectual property and the offering in general, can be found in the risk factor section of the Form 1-A offering circular.

Investor Relations Contact

JTC Team, LLC

Jenene Thomas 

833-475-8247

autonomix@jtcir.com 

Stay Up-to-Date With The Future of Autonomix
Privacy Policy

Autonomix is committed to protecting your privacy. This Privacy Policy outlines our practices concerning the collection, use, and protection of your personal information when you visit our website or use our services.

1. Information We Collect

We may collect personal information that you voluntarily provide to us, including but not limited to:

  • Name
  • Email address
  • Contact information
  • Billing and payment details
  • User-generated content (e.g., comments, reviews)

We may also collect non-personal information, such as:

  • Browser type
  • IP address
  • Device information
  • Cookies and usage data

2. How We Use Your Information

We may use your personal information for various purposes, including but not limited to:

  • Providing, maintaining, and improving our website and services.
  • Processing transactions and payments.
  • Sending updates, newsletters, and promotional materials.
  • Responding to your inquiries and requests.
  • Complying with legal obligations.


3. Cookies and Tracking Technologies

We use cookies and similar tracking technologies to collect information about your browsing behavior on our website. You can manage your cookie preferences through your browser settings.

4. Disclosure of Your Information

We may share your personal information with third parties under the following circumstances:

  • With your consent.
  • To comply with legal obligations.
  • To protect our rights, privacy, safety, or property.
  • In connection with the sale, merger, or acquisition of all or part of our business.

5. Your Rights

You have the right to:

  • Access, update, or delete your personal information.
  • Object to the processing of your personal information.
  • Withdraw your consent, where applicable.
  • Lodge a complaint with a supervisory authority.

6. Data Security

We take reasonable measures to protect your personal information from unauthorized access, disclosure, alteration, or destruction. However, no method of data transmission over the internet or electronic storage is entirely secure. Therefore, we cannot guarantee its absolute security.

7. Children’s Privacy

Our website and services are not intended for children under the age of 13. We do not knowingly collect personal information from children. If you believe that a child has provided us with their personal information, please contact us, and we will take appropriate steps to delete the information.

8. Changes to this Privacy Policy

We may update this Privacy Policy from time to time to reflect changes in our practices or for other operational, legal, or regulatory reasons. We encourage you to review this Privacy Policy periodically for any updates.

9. Contact Us

If you have any questions or concerns about this Privacy Policy or our data practices, please contact us at autonomix@jtcir.com.

Terms & Conditions

1. Acceptance of Terms

By accessing and using this website, you agree to abide by these Terms and Conditions, as well as any applicable laws and regulations. If you do not agree with these terms, please refrain from using this website.

2. Use of Content

All content on this website, including but not limited to text, images, graphics, videos, and logos, is the property of Autonomix or its affiliates and is protected by intellectual property laws. You may not reproduce, distribute, or display any content without prior written permission.

3. User Conduct

You agree not to engage in any of the following activities while using this website:

  • Violating any applicable laws or regulations.
  • Uploading or transmitting any content that is harmful, offensive, or infringing on the rights of others.
  • Attempting to gain unauthorized access to the website, its servers, or user data.
  • Interfering with the website’s functionality or security.

4. Privacy Policy

Your use of this website is also governed by our Privacy Policy, which outlines how we collect, use, and protect your personal information. By using this website, you consent to the practices described in our Privacy Policy.

5. Links to Third-Party Websites

This website may contain links to third-party websites. These links are provided for convenience only, and Autonomix does not endorse or assume responsibility for the content or practices of these websites. Accessing third-party websites is at your own risk.

6. Disclaimer of Warranties

This website is provided “as is,” without any warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose, or non-infringement. Autonomix does not warrant that the website will be error-free or uninterrupted.

7. Limitation of Liability

To the fullest extent permitted by law, Autonomix shall not be liable for any direct, indirect, incidental, consequential, or punitive damages arising out of or related to your use of this website. This includes but is not limited to any loss of data or profits.

8. Governing Law

These Terms and Conditions shall be governed by and construed in accordance with the laws of the United States. Any disputes arising under these terms shall be subject to the exclusive jurisdiction of the courts in the United States.

9. Changes to Terms and Conditions

Autonomix reserves the right to modify or revise these Terms and Conditions at any time. It is your responsibility to review this page periodically for updates. Your continued use of the website after any changes signifies your acceptance of the revised terms.

10. Contact Information

If you have any questions or concerns about these Terms and Conditions, please contact us at autonomix@jtcir.com.

Be The First To Get Updates About Autonomix
Skip to content